Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited Metabolic Disease

The FDA cited deficiencies in its govorestat’s application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. The post Applied Therapeutics Drug Is Denied FDA Approval in Rare…

Read More

Only 2 weeks left for January 1 coverage

Apply for, renew, or change your Marketplace plan by December 15 to make sure your coverage starts January 1.   Image Already have Marketplace coverage? Whether you want to keep your current coverage or you’re ready for a change, you should log into your account to update any income or household changes for next year. This…

Read More